CSMYF(CSMYF)
CSMYF
No analyst ratings available
No analyst price targets available for CSMYF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $1.15T | $1.23T | $1.35T | $1.44T |
| Low | $1.12T | $1.19T | $1.31T | $1.40T |
| High | $1.18T | $1.26T | $1.38T | $1.47T |
| EBITDA Avg | $73.08B | $78.04B | $85.34B | $91.25B |
| Low | $70.77B | $75.58B | $82.64B | $88.36B |
| High | $74.61B | $79.67B | $87.12B | $93.15B |
| EBIT Avg | $49.39B | $52.74B | $57.67B | $61.67B |
| Low | $47.83B | $51.08B | $55.85B | $59.72B |
| High | $50.42B | $53.84B | $58.88B | $62.95B |
| Net Income Avg | $32.32B | $34.06B | $39.87B | $42.29B |
| Low | $31.00B | $32.66B | $38.23B | $40.56B |
| High | $33.20B | $34.98B | $40.95B | $43.44B |
| EPS Avg | $407.82 | $429.72 | $503.03 | $533.63 |
| Low | $391.08 | $412.07 | $482.38 | $511.71 |
| High | $418.88 | $441.37 | $516.67 | $548.09 |
| Analysts (Rev / EPS) | 10 / 1 | 4 / 1 | 5 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $291.09B | $279.74B | $287.20B | $299.72B |
| Low | $288.47B | $277.22B | $284.61B | $297.02B |
| High | $294.56B | $283.08B | $290.62B | $303.30B |
| EBITDA Avg | $18.42B | $17.71B | $18.18B | $18.97B |
| Low | $18.26B | $17.55B | $18.01B | $18.80B |
| High | $18.64B | $17.92B | $18.39B | $19.20B |
| EBIT Avg | $12.45B | $11.97B | $12.29B | $12.82B |
| Low | $12.34B | $11.86B | $12.17B | $12.71B |
| High | $12.60B | $12.11B | $12.43B | $12.97B |
| Net Income Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| EPS Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 1 / — | 2 / — | 2 / — |